{
    "clinical_study": {
        "@rank": "23568", 
        "arm_group": {
            "arm_group_label": "Cancer Pain", 
            "description": "Placement of an intrathecal pump"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the changes in immune function, as measured by\n      biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid\n      medications for the treatment of moderate to severe cancer pain.\n\n      Hypothesis: Treatment of pain with intrathecal (spinal) therapy is associated with little\n      alteration of immune function as measured by biomarkers in the blood of  cancer patients\n      with moderate to severe pain."
        }, 
        "brief_title": "Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Cancer-associated Pain", 
        "detailed_description": {
            "textblock": "Biomarkers of immune function will be measured before and after patients receive an\n      intrathecal pain pump for management of cancer pain."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of cancer\n\n          -  Evaluation by a pain management physician and confirmation that cancer is the primary\n             etiology of patient's pain\n\n          -  Moderate to severe pain, as specified by a baseline Pain Rating Score of 5 or above\n             on a scale from 0 (no pain) to 10 (worst pain imaginable) despite current opioid\n             therapy\n\n          -  Pain management plan (as developed by Interventional Pain Service, patient and\n             primary service) that includes placement of an intrathecal drug delivery system for\n             pain management\n\n          -  Able and willing to give informed consent\n\n        Exclusion Criteria:\n\n          -  Patients with an expected life expectancy of less than 12 weeks\n\n          -  Patients not felt be a safe surgical candidate by pain management physician for\n             placement of and intrathecal drug delivery system (IDDS) due to the presence of\n             severe medical comorbidities\n\n          -  Patients who are not a candidate for intrathecal drug therapy due to coagulopathy,\n             concurrent necessary use of blood thinners, presence of systemic infection, drug\n             allergy to analgesic agent, evidence of CSF obstruction or other technical factor\n\n          -  Severe or untreated psychiatric disease\n\n          -  Refusal of informed consent\n\n          -  Pregnant patients or patients less than 18 years of age"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with cancer-associated pain who are receiving an intrathecal pump for management\n        of cancer pain"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02151513", 
            "org_study_id": "IRB_00057738"
        }, 
        "intervention": {
            "arm_group_label": "Cancer Pain", 
            "intervention_name": "Intrathecal Pump Placement", 
            "intervention_type": "Device", 
            "other_name": "Medtronic SyncroMed II"
        }, 
        "intervention_browse": {
            "mesh_term": "Analgesics, Opioid"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cancer-associated pain", 
            "Immune function"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Salt Lake City", 
                    "country": "United States", 
                    "state": "Utah", 
                    "zip": "84112"
                }, 
                "name": "Huntsman Cancer Hosptial"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in biomarker values", 
            "safety_issue": "No", 
            "time_frame": "Before, 4 weeks after and 8 weeks after intrathecal pump placement"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02151513"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Utah", 
            "investigator_full_name": "Shane Brogan", 
            "investigator_title": "Associate Professor, Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Quality of life surveys", 
            "measure": "Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "Before, 4 weeks after and 8 weeks after intrathecal pump placement"
        }, 
        "source": "University of Utah", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Utah", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}